EMA Seeks To Extend EudraVigilance Pilot For Another Year
Executive Summary
The pilot was launched to support a phased implementation of new EU requirements relating to monitoring and reporting drug safety information.
You may also be interested in...
EU Extends Pilot Of New Drug Safety Reporting System
Testing of the enhanced EU drug safety reporting system, EudraVigilance, is to be extended beyond February in an effort to gain more information on how stakeholders are finding the new requirements.
EMA Postpones Decision On Next Phase Of EudraVigilance To End Of 2019
The European Commission has agreed to extend the ongoing signal detection pilot involving the revamped EU pharmacovigilance database and has asked for a report on experience in the first year.
Industry/EMA Discuss Early Concerns Over EU’s Safety Signal Reporting Pilot
Industry representatives have raised some issues around the EU’s pilot program for drug safety signal monitoring and reporting via the revamped EudraVigilance system.